Selective mechanism of action of dietary peptides from common bean on HCT116 human colorectal cancer cells through loss of mitochondrial membrane potential and DNA damage

Journal of Functional Foods

Volumn 23, Issue , 2016, Pages 24-39

  Luna Vital, Diego A ^a,b   González de Mejía, Elvira ^b   Loarca Piña, Guadalupe ^a  

^a UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Bioactive peptides; Colorectal cancer; Common bean; Oxaliplatin; Synergistic interaction

Indexed keywords

EID: 84959161050     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.02.021     Document Type: Article

References (49)

1. Abbas T., Dutta A. p21 in cancer: Intricate networks and multiple activities. Nature Reviews. Cancer 2009, 9:400-414.
2. Berlett B.S., Levine R.L. Designing antioxidant peptides. Redox Report: Communications in Free Radical Research 2014, 19:80-86.
3. Boland C.R., Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010, 138:2073-2087.
4. Chou T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacological Reviews 2006, 58:621-681.
5. Dia V.P., Gonzalez de Mejia E. Lunasin induces apoptosis and modifies the expression of genes associated with extracellular matrix and cell adhesion in human metastatic colon cancer cells. Molecular Nutrition and Food Research 2011, 55:623-634.
6. Dun Y., Vargas J., Brot N., Finnemann S.C. Independent roles of methionine sulfoxide reductase A in mitochondrial ATP synthesis and as antioxidant in retinal pigment epithelial cells. Free Radical Biology and Medicine 2013, 65:1340-1351.
7. Fauzi A.N., Norazmi M.N., Yaacob N.S. Tualang honey induces apoptosis and disrupts the mitochondrial membrane potential of human breast and cervical cancer cell lines. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 2011, 49:871-878.
8. Gaspar D., Veiga A.S., Castanho M.A. From antimicrobial to anticancer peptides. A review. Frontiers in Microbiology 2013, 4. article 294.
9. Ghavami S., Asoodeh A., Klonisch T., Halayko A.J., Kadkhoda K., Kroczak T.J., Gibson S.B., Booy E.P., Naderi-Manesh H., Los M. Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. Journal of Cellular and Molecular Medicine 2008, 12:1005-1022.
10. Graham J., Muhsin M., Kirkpatrick P. Oxaliplatin. Nature Reviews Drug Discovery 2004, 3:11-12.
11. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wisknok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Analytical Biochemistry 1982, 126:131-138.
12. Halazonetis T.D., Gorgoulis V.G., Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008, 319:1352-1355.
13. Heo J.I., Oh S.J., Kho Y.J., Kim J.H., Kang H.J., Park S.H., Kim H.S., Shin J.Y., Kim M.J., Kim M., Kim S.C., Park J.B., Kim J., Lee J.Y. ATM mediates interdependent activation of p53 and ERK through formation of a ternary complex with p-p53 and p-ERK in response to DNA damage. Molecular Biology Reports 2012, 39:8007-8014.
14. Hoskin D.W., Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochimica et Biophysica Acta 2008, 1778:357-375.
15. Howells L.H., Mitra A., Manson M. Comparison of oxaliplatin-and curcumin-mediated antiproliferative effects in colorectal cell lines. International Journal of Cancer 2007, 121:175-183.
16. Johnson J.L., de Mejia E.G. Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 2013, 60:83-91.
17. Jung Y., Qian Y., Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cellular Signalling 2010, 22:1003-1012.
18. Kai K., Nagano O., Sugihara E., Arima Y., Sampetrean O., Ishimoto T., Nakanishi M., Ueno N.T., Iwase H., Saya H. Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model. Cancer Science 2009, 100:2275-2282.
19. Kay J.G., Koivusalo M., Ma X., Wohland T., Grinstein S. Phosphatidylserine dynamics in cellular membranes. Molecular Biology of the Cell 2012, 23:2198-2212.
20. Kiyonari S., Iimori M., Matsuoka K., Watanabe S., Morikawa-Ichinose T., Miura D., Nimi S., Saeki H., Tokunaga E., Oki E., Morita M., Kadomatsu K., Maehara Y., Kitao H. The 1,2-diaminocyclohexane carrier ligand in oxaliplatin induces p53-dependent transcriptional repression of factors involved in thymidylate biosynthesis. Molecular Cancer Therapeutics 2015, 14:2332-2342.
21. Lee H.S., Park C.B., Kim J.M., Jang S.A., Park I.Y., Kim M.S., Cho J.H., Kim S.C. Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Cancer Letters 2008, 271:47-55.
22. Lee J.H., Paull T.T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 2004, 304:93-96.
23. Li J., Liu Y., Fan L., Ai L., Shan L. Antioxidant activities of polysaccharides from the fruiting bodies of Zizyphus Jujuba cv. Jinsixiaozao. Carbohydrate Polymers 2011, 84:390-394.
24. Li Y.H., Jiang B., Zhang T., Mu W.M., Liu J. Antioxidant and free radical scavenging activities of chickpea protein hydrolysate (CPH). Food Chemistry 2008, 106:444-450.
25. Lu J., Ho C.T., Ghai G., Chen K.Y. Differential effects of theaflavin monogallates on cell growth, apoptosis, and Cox-2 gene expression in cancerous versus normal cells. Cancer Research 2000, 60:6465-6471.
26. Luna Vital D.A., González de Mejía E., Dia V.P., Loarca-Piña G. Peptides in common bean fractions inhibit human colorectal cancer cells. Food Chemistry 2014, 157:347-355.
27. Luna Vital D.A., Loarca-Piña G., Dia V.P., González de Mejía E. Peptides extracted from common bean (Phaseolus vulgaris L.) non-digestible fraction caused differential gene expression of HCT116 and RKO human colorectal cancer cells. Food Research International 2014, 62:193-204.
28. Luna-Vital D.A., Gonzalez de Mejia E., Mendoza S., Loarca-Pina G. Peptides present in the non-digestible fraction of common beans (Phaseolus vulgaris L.) inhibit the angiotensin-I converting enzyme by interacting with its catalytic cavity independent of their antioxidant capacity. Food & Function 2015, 6:1470-1479.
29. Mader J.S., Hoskin D.W. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opinion on Investigational Drugs 2006, 8:933-946.
30. Makovski A., Yaffe E., Shpungin S., Nir U. Down-regulation of Fer induces ROS levels accompanied by ATM and p53 activation in colon carcinoma cells. Cellular Signalling 2012, 24:1369-1374.
31. Miki H., Funato Y. Regulation of intracellular signaling through cysteine oxidation by reactive oxygen species. The Journal of Biochemistry 2012, 151:255-261.
32. Mirzayans R., Andrais B., Scott A., Murray D. New insights into p53 signaling and cancer cell response to DNA damage: Implications for cancer therapy. Journal of Biomedicine and Biotechnology 2012, article ID: 170325.
33. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Campbell H., Mayo J., Boyd M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. Journal of the National Cancer Institute 1991, 83:757-766.
34. Narayanan A., Baskaran S.A., Amalaradjou M.S.R., Venkitanarayanan K. Anticarcinogenic properties of medium chain fatty acids on human colorectal, skin and breast cancer cells in vitro. International Journal of Molecular Sciences 2015, 16(3):5014-5027.
35. Nessa M.U., Beale P., Chan C., Yu J.Q., Huq F. Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models. Anticancer Research 2012, 32:4843-4850.
36. Papo N., Shai Y. Host defense peptides as new weapons in cancer treatment. Cellular and Molecular Life Sciences 2005, 62:784-790.
37. Patsos G., André S., Roeckel N., Gromes R., Gebert J., Kopitz J., Gabius H. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): A gene-dependent effect on the cell surface glycan profile. Glycobiology 2009, 19:726-734.
38. Saito S., Yamagucho H., Higashimoto Y., Chao C., Xu Y., Fornace A.J., Appella E., Anderson C. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. The Journal of Biological Chemistry 2003, 278:37536-37544.
39. Sharma A., Singh K., Almasan A. Histone H2AX phosphorylation: A marker for DNA damage. DNA repair protocols 2012, 613-626. Humana Press.
40. Singh T., Sharma S.D., Katiyar S.K. Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo. PLoS ONE 2011, 6. 10.1371/journal.pone.0027444.
41. Soldani C., Lazze M.C., Bottone M.G., Tognon G., Biggiogera M., Pellicciari C.E., Scovassi A.I. Poly (ADP-ribose) polymerase cleavage during apoptosis: When and where?. Experimental Cell Research 2001, 269:193-201.
42. Sosa V., Moliné T., Somoza R., Paciucci R., Kondh H., Lleonart M.E. Oxidative stress and cancer: An overview. Ageing Research Reviews 2013, 2013(12):376-390.
43. Su L.Y., Xin H.Y., Liu Y.L., Zhang J.L., Xin H.W., Su X.L. Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A). Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 2014, 35:10051-10056.
44. Tallarida R.J. An overview of drug combination analysis with isobolograms. The Journal of Pharmacology and Experimental Therapeutics 2006, 319:1-7.
45. Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?. Nature Reviews Drug Discovery 2009, 8:579-591.
46. Velimezi G., Liontos M., Vougas K., Roumeliotis T., Bartkova J., Sideridou M., Dereli-Oz A., Kocylowski M., Pateras I.S., Evangelou K., Kotsinas A., Orsolic I., Bursac S., Cokaric-Brdovcak M., Zoumpourlis V., Kletsas D., Papafotiou G., Klinakis A., Volarevic S., Gu W., Bartek J., Halazonetis T.D., Gorgoulis V.G. Functional interplay between the DNA-damage response kinase ATM and ARF tumour suppressor protein in human cancer. Nature Cell Biology 2013, 15:966-977.
47. Wang M., Ruan Y., Chen Q., Li S., Wang Q., Cai J. Curcumin induced HepG2 cell apoptosis-associated mitochondrial membrane potential and intracellular free Ca 2+ concentration. European Journal of Pharmacology 2011, 650:41-47.
48. World Health Organization Website, Accessed 07.15. http://www.who.int/.
49. Wu H.C., Chen H.M., Shiau C.Y. Free amino acids and peptides as related to antioxidant properties in protein hydrolysates of mackerel (Scomber austriasicus). Food Research International 2003, 36:949-957.